Altamira Therapeutics Ltd. Current Financial Assets At Amortised Cost
Altamira Therapeutics Ltd. (CYTOF) had Current Financial Assets At Amortised Cost of CHF 13.50 million as of 2022-12-31, per its 20-F filed 2023-05-16.
Discontinued › Notes
ifrs-full:CurrentFinancialAssetsAtAmortisedCost · last filed 2023-05-16
- 2022-12-31: Current Financial Assets At Amortised Cost 13.50M CHF.
- 2021-12-31: Current Financial Assets At Amortised Cost 5.37M CHF.
| Period end | Current Financial Assets At Amortised Cost |
|---|---|
| 2022-12-31 | 13.50M CHF 20-F · filed 2023-05-16 |
| 2021-12-31 | 5.37M CHF 20-F · filed 2023-05-16 |